Prevalence and risk factors of HPV infection among women from various provinces of the world

Archives of Gynecology and Obstetrics

Volumn 285, Issue 3, 2012, Pages 771-777

  Vinodhini, Krishnakumar ^a   Shanmughapriya, Santhanam ^a   Das, Bhudev C ^b   Natarajaseenivasan, Kalimuthusamy ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Cervical carcinoma; Human papilloma virus; Prevalence; Risk factors

Indexed keywords

ONCOPROTEIN; VIRUS DNA;

AFRICA; AGE; AMINO ACID SEQUENCE; ARTICLE; ASIA; BETEL NUT; CHINA; CIGARETTE SMOKING; CONTRACEPTION; DEVELOPED COUNTRY; DISEASE SEVERITY; DNA DETERMINATION; EUROPE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INDIA; LIFESTYLE; MARRIAGE; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PARITY; PHYLOGENY; PREVALENCE; RISK FACTOR; SEQUENCE HOMOLOGY; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SYSTEMATIC REVIEW; UNITED STATES; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS TYPING; WART VIRUS; AUSTRALIA; GENETICS; ISOLATION AND PURIFICATION; REVIEW; SEXUALITY; VIROLOGY; WESTERN HEMISPHERE;

AFRICA; AMERICAS; ASIA; AUSTRALIA; EUROPE; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; PREVALENCE; RISK FACTORS; SEXUAL PARTNERS;

EID: 84863198724     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2155-8     Document Type: Article

References (26)

1. Curado MP, Edwards B, Shin HR et al (eds) (2007) Cancer incidence in Wve continents. In: IARC ScientiWc Publications, 9th edn. International Agency for Research on Cancer, Lyon, France.
2. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of twenty-Wve major cancers in 1990. Int J Cancer 80:827-841.
3. Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606.
4. Ferlay J, Parkin DM, Pisani P (1998) GLOBOCAN 1: cancer incidence and mortality worldwide. IARC Cancer Base no. IARC Press, Lyon.
5. Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
6. de Sanjose S, Diaz M, Castellsague X et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453-459.
7. Centers for disease control and prevention (2007) Epidemiology and prevention of vaccine-preventable diseases, 10th edn. Public Health Foundation, Washington.
8. Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12(2):186-192.
9. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase 2.0 edn. IARC Press, Lyon.
10. Li LK, Dai M, CliVord GM et al (2006) Human papilloma virus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 95:37-1593.
11. Wen-ying Zhang, Yue-zhen Xue et al (2008) Prevalence of highrisk human papillomavirus infection in diVerent cervical lesion among organized health-examination women in Shanghai, China. Chin Med J 121:1578-1582.
12. Liu J, Rose B, Huang X et al (2004) Comparative analysis of characteristics of women with cervical cancer in high-versus low incidence regions. Gynecol Oncol 94:803-810.
13. Anon (2005) UNAIDS: global AIDS epidemic just beginning. AIDS Policy Law 20:1.
14. Currin LG, Jack RH, Linklater KM et al (2009) Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health. doi:10.1186/1471-2458-9-62.
15. Moreno V, Bosch FX, Munoz N et al (2002) EVect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 30:1085-1092.
16. Ragin CC,Watt RA,Markovic N et al (2009) Comparisons of highrisk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer. doi:10.1186/1750-9378-4-S1-S9.
17. Thomas JO, Herrero R, Omigbodun AA et al (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 90:638-645.
18. Bhatla N, Lal N, Bao YP et al (2008) A meta analysis of human papillomavirus type-distribution in women from south Asia: implications for vaccination. Vaccine 26:2811-2817.
19. Bayo S, Bosch FX, Sanjose DS et al (2002) Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 31:202-209.
20. Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89:229-240.
21. Strickler HD, Palefsky JM, Shah KV et al (2003) Human papillomavirus type 16 and immune status in human immunodeWciency virus seropositive women. J Natl Cancer Inst 95:1062-1071.
22. CliVord G, Gallus S, Herrero R et al (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991-998.
23. Biswas C, Kell B, Mant C et al (1997) Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology. J Clin Microbiol 35:1560-1564.
24. Parkin DM, Pisani P, Ferlay J et al (1999) Estimates of the worldwide incidence of twenty-Wve major cancers in 1990. Int J Cancer 80:827-841.
25. Balaram P, Sridhar H, Rajkumar T et al (2002) Oral cancer in Southern India: the inXuence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 98:440-444.
26. Szarewski A, Cuzick J et al (1998) Smoking and cervical neoplasia: a review of the evidence. J Epidemiol Biostat 3:229-256